# Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA

> **NCT03926260** · NA · COMPLETED · sponsor: **Centre Hospitalier Departemental Vendee** · enrollment: 100 (actual)

## Conditions studied

- Metastatic Non-small Cell Lung Cancer

## Interventions

- **OTHER:** ctDNA analysis

## Key facts

- **NCT ID:** NCT03926260
- **Lead sponsor:** Centre Hospitalier Departemental Vendee
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-27
- **Primary completion:** 2021-07-30
- **Final completion:** 2022-05-23
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03926260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03926260, "Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03926260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*